Scientists at the University of Oxford, U.K., use a precise new surface plasmon resonance method to measure very low affinities of T cell receptor binding to self and non-self peptides presented on MHC to show that TCRs are not prefect in their ability to distinguish between healthy and infected cells, as was earlier believed. These new results open new possibilities for treating autoimmune diseases and cancer.